ZMUni Compliance Centre

From October 16 to 24, 2025, 4 new cosmetic ingredients (NCIs) were notified with the China National Medical Products Administration (NMPA).      The technical requirements for the 4 new cosmetic ingredients mentioned above have not been disclosed, and they have not yet entered the safety monitoring period.   Another noteworthy update is that on October 20, 2025, the NMPA released the second dynamic adjustment of the Inventory of Existing Cosmetic Ingredients in China (IECIC) this year, which involved the inclusion of three new cosmetic ingredients in the IECIC List II (bringing the total to five).   For details, please refer to our previous article: China Existing

      On October 20, 2025, China's National Institutes for Food and Drug Control (NIFDC) launched the first batch of new cosmetic ingreidents (NCIs) for innovation guidance. The selected NCIs were chosen based on four key criteria: first-to-market, Chinese characteristics, domestic substitution, and green low-carbon development.   This initiative aims to implement the Several Provisions on Supporting Cosmetic Ingredient Innovation and strengthen services for the innovation and application of new cosmetic ingredients.   Note: Being included in the innovation guidance list does not indicate that an ingredient's safety or quality has been approved. R&D must still comply with relevant regulations, and

    On October 20, 2025, China's National Medical Products Administration (NMPA) announced a three-year pilot program for electronic cosmetic labels, marking a significant step toward the digital transformation of cosmetic labeling in China. The pilot will begin on February 1, 2026, and will be implemented in Beijing, Shanghai, Zhejiang, Shandong, Guangdong, and Chongqing. The duty-free cosmetics pilot on Hainan Island, launched locally in September 2024, may also be carried out under the new NMPA requirements.   The pilot aims to optimize labeling management, enhance consumer access to product information, address the needs of elderly users, and facilitate business operations,

 On October 20, 2025, China's National Medical Products Administration (NMPA) has carried out the second dynamic update of the Inventory of Existing Cosmetic Ingredients in China (IECIC), following the first update earlier this year, which set the precedent for regular adjustments to ensure ingredient safety and regulatory compliance.   The updates to the inventory specifically includes:   List II of IECIC: 3 New Cosmetic Ingredients Included According to relevant regulations, new cosmetic ingredients (NCIs) that have completed a three-year safety monitoring period are reviewed by technical evaluation bodies. If deemed to meet safety requirements, they are officially included in List II of the IECIC.   Following the previous inclusion

Earlier this year, the Shanghai Medical Products Administration fined a foreign cosmetic registrant whose designated Domestic Responsible Person (DRP) failed to assist in adverse event monitoring and product recalls.    This case highlights a crucial reality for overseas brands entering China: the China RP is not just a formal contact — it is the legal "first responder" for compliance and product safety, bearing direct administrative liability under Chinese law. Understanding the obligations and risks associated with this role is essential for any foreign brand seeking a smooth and compliant entry into the Chinese market.   What Is a "Domestic Responsible Person" in China?

    On October 14,2025, China's National Institutes for Food and Drug Control (NIFDC) released 6 draft cosmetic standards for public consultation. These drafts include four test methods and two regulations, with the consultation period open until November 7, 2025.   The drafts are as follows: 1. 90-day Oral Toxicity Study 2. 90-day Dermal Toxicity Study 3. Bacterial Reverse Mutation Test 4. In Vitro Mammalian Cells Chromosome Aberration Test 5. General Principles of Cosmetic Product Standards 6. Technical Guidelines on the Intended Use of Cosmetic Ingredients

From October 1 to 15, 2025, 10 new cosmetic ingredients were notified with the China National Medical Products Administration (NMPA).       The technical requirements for the 10 new cosmetic ingredients mentioned above have not been disclosed, and they have not yet entered the safety monitoring period.   Schizosaccharomyces Pombe Ferment Lysate Filtrate Schizosaccharomyces pombe is one of the commonly used strains in the fermentation industry. It belongs to the group of non-Saccharomyces cerevisiae yeasts, together with Schizosaccharomyces japonicus and Schizosaccharomyces octosporus, forming the genus Schizosaccharomyces.   According to the official website of SHE'S YEA, a brand under the notifier Shanghai Yuancui Biotechnology, its Hydrolyzed

  On October 14, 2025, the General Administration of Customs of China(GACC) officially issued the Regulations on the Registration and Administration of Overseas Manufacturers of Imported Food (Decree No. 280), which will take effect on June 1, 2026. Upon its implementation, Decree No. 248, released on April 12, 2021, will be repealed.   The new regulation was first published as a draft for public consultation on January 3, 2025, together with the Catalogue of Foods Requiring Official Recommendation for Registration (Draft for Comments), which has not yet been released.   Below is a brief comparison highlighting the key changes between Decree No. 248 and Decree No.